chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately Felt Dizzy like she was being spun around; like she was being spun around; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Immediately Felt Dizzy like she was being spun around) and VERTIGO (like she was being spun around) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Immediately Felt Dizzy like she was being spun around) and VERTIGO (like she was being spun around). The patient was treated with MORPHINE (intravenous) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Immediately Felt Dizzy like she was being spun around) and VERTIGO (like she was being spun around) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided for by the reporter for the 1st vaccine dose.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-187063 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
COVID-19 case I thought I was having an allergy attack. My daughter's household all had COVID-19 and we were just with them. I tested and was positive. I called my Dr. and he advised don't take the  antiviral medication .   I never had a temperature and my pulse ox was fine. I had a little nasal congestion and fatigue but that's waning at this point. My experience was pretty minimal.
rash on her face, upper body, both arms all the way to hands, abdomen, but not on the back; This is a spontaneous report from a contactable nurse reporting for herself. A 72-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on 11Jan2021 as single dose for COVID-19 immunization. The patient medical history included allergic to penicillin. Concomitant medications were not reported. The patient stated that, she received the first dose of the Pfizer covid vaccine on 11Jan, on the 14Jan she developed rash on her face, upper body, both arms all the way to hands, abdomen, but not on the back (as reported). She was concerned if she should take the second dose or not and if she does take the second dose would her symptoms be more severe or delayed reaction like she got with the first dose. Outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Child developed vomiting and diarrhea. ROTATEQ given on 11-12-13.
Dizziness, Myalgia, NauseaVomiting,  Nausea 1/25, next day fatigue, arm pain, chills, dizziness; a;; symptoms resolved. Narrative:
1st shot: No side effects after 1st vaccine shot other than slight bruise-like pain at site of injection (upper left . 2nd shot: 27 hours after, fatigue, general malaise, and light headache noticed.  29 hours after, minor swelling of left armpit with associated minor discomfort.  After sleep, all symptoms gone save swelling which has increased.  Noticeable overall swelling in the area visibly, inferior of armpit.  At time of report (17:30 11 May 2021), swelling persists but pain reduced.
chills; aches; I feel faint; had a lump form at the site of injection; now it's just sore/ vaccination site sore; I believe my reaction was due to the manner in which it was administered; lump form at the site of injection immediately and it bled; shaky; Sweat; hearing gets muffled; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE HAEMORRHAGE (lump form at the site of injection immediately and it bled), TREMOR (shaky), HYPERHIDROSIS (Sweat), HYPOACUSIS (hearing gets muffled) and PAIN (aches) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 203G23A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. On 30-Oct-2023, the patient experienced VACCINATION SITE HAEMORRHAGE (lump form at the site of injection immediately and it bled), TREMOR (shaky), HYPERHIDROSIS (Sweat), HYPOACUSIS (hearing gets muffled), PRESYNCOPE (I feel faint), VACCINATION SITE MASS (had a lump form at the site of injection), VACCINATION SITE PAIN (now it's just sore/ vaccination site sore) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (I believe my reaction was due to the manner in which it was administered). On 31-Oct-2023, the patient experienced PAIN (aches) and CHILLS (chills). At the time of the report, VACCINATION SITE HAEMORRHAGE (lump form at the site of injection immediately and it bled), TREMOR (shaky), HYPERHIDROSIS (Sweat), HYPOACUSIS (hearing gets muffled), PRESYNCOPE (I feel faint) and VACCINATION SITE MASS (had a lump form at the site of injection) had resolved, PAIN (aches), CHILLS (chills) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (I believe my reaction was due to the manner in which it was administered) outcome was unknown and VACCINATION SITE PAIN (now it's just sore/ vaccination site sore) had not resolved.            No concomitant medication was reported.  Patient reported that, after receiving Spikevax, the pharmacist seemed to have trouble with the injection. Patient had a lump formed at the site of injection immediately and it bled. Patient sometimes have trouble when giving blood. Patient got shaky, sweat, hearing gets muffled, and felt faint. This happened when patient received the vaccine.  Although, patient believed the reaction was due to the manner in which it was administered and his/her reaction to it, patient wanted to be sure and report it. Patient sat for several minutes and had some juice and was able to walk around the store for 10 minutes and then went home. On the reporting day, patient had had some chills and aches, but the injection site was fine. The lump went down and now it was just sore.  No treatment information was provided.
one side of face swollen; hives to one side of her face; This is a spontaneous report from a contactable consumer. This contactable consumer reported that a 16-year-old female patient (reporter's daughter) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine) at right arm at single dose for COVID-19 immunisation on 10Aug2021 at 3:45 pm (16-year-old at the time of vaccination). Relevant history was none. Relevant concomitant drug was none.  The patient woke up with one side of face swollen with hives at the next morning (11Aug2021). The mother told her to take Benadryl and she had taken that so far. The patient had gone to a clinic.  The outcome of events was not resolved; the hives and swelling to one side of her face were worsened.  Relevant lab test was none.     The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Headache, Myalgia, Arthralgia, Fever, Diarrhea, fever, headache, weakness, muscle aches, diarrhea, site soreness, right arm tingling and entire arm sore Narrative: OTC Tylenol and Ibuprofen
30yo female with no documented allergies received COVID-19 Pfizer BioNTech vaccination, dose#1.  Patient c/o feeling warm, blotchy across her face and chest.  Stated she was really nervous about receiving the vaccine. Monitored for 45 minutes under direct observation of clinic staff.  Initial SBP 156 and decreased to 120/80s.  Denies nausea, drinking water. Remained on 100% RA. Blotches appear less bright. Asked to go back to work. No dizziness, ambulated to door without problems. Discharged to self and returned to work.
Rash on neck and chest, facial swelling. Symptoms began Friday, two days after injection, are still present now, Sunday, two days after they began.
11/15/19 Prior to imms. pt's temp was 98.8F per 2 different thermometers. After imms was administered, pt had gotten off exam table for dad to help her with putting on her coat. Pt slumped & became limp as dad was lifting her. Pt never lost consciousness, but became limp, pale, & unresponsive to verbal commands for aprox 30-40 seconds. No sz activity was noted & pt had her eyes open the entire time. Pt was placed on exam table & help was called. Pt immediately became responsive verbally & physically and color returned to her face. Pt was A&Ox3. Vitals @ 2:37pm were: B/P 82/64, temp 98.5F, HR 82, O2 98% & blood sugar 108. Pt's dad stated that "the same thing happened to me after getting my blood drawn in college & they found that I had a heart murmur. But it hasn't happened since then." Pt was evaluated by FNP & no heart murmur was noted. Dad stated that pt "had a late lunch & candy" when asked when had pt last eaten. Both writer & FNP stated & stressed importance of pt eating a meal with protein & less sugar after leaving clinic & pt being evaluated by her primary physician & or urgent care center asap. Dad verbalized understanding. At aprox 2:50pm, writer assisted pt & dad to check out & pt was noted to be walking independently & playing down the hallway by jumping from tile to tile to "avoid stepping on the tile cracks". 11/18/19 FU PC to dad. Dad stated pt was "sick all weekend with her temp going up to 102 degrees", however, she was given Tylenol & fever went down. Dad states that her mother "is currently taking care of her." Writer strongly urged either him or pt's (M) to take pt to her primary pediatrician or urgent care today to be evaluated. Dad verbalized understanding & stated that pt's "mother is supposed to be taking care of that." Dad states that pt has been "jumping around" & playing despite being sick & denies any further problems or needs @ this time.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown ages and genders. On unknown dates, the patients were vaccinated with improperly stored PEDVAXHIB (lot # reported as M001814, expiry date: 15-OCT-2018; lot # L051122, expiry date: 12-OCT-2018) via intramuscular route. No adverse effect reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
2/14/21 - 2 weeks after the 2nd Covid Vaccine dose, I developed extreme and sudden GI issues such as loss of appetite, nausea, chronic diarrhea, weight loss, and stomach pain.  I could not eat or drink anything without needing to purge immediately. I saw my PCP who took blood (normal) and stool samples (normal) and referred me to a GI.  April of 2021, I had an endoscopy and colonoscopy. Endoscopy revealed Esophageal Eosinophils under biopsy. I was told I had EOE and was put on a PPI medication. My condition did not improve until July/Aug when the multiple daily diarrhea's waned and my appetite started to increase. Sept 2nd, I received the Covid Booster and exactly 2 weeks later I lost my appetite, nausea, diarrhea, and stomach pains began again. I am still having GI issues and in fact have another endoscopy tomorrow am .
Pt started on rabies vaccine prophylactic when dog not at first available for observation post dog bite .Given on 1/22, 1/25, 1/29. Had nausea after 1st two shots times 1 hour. 3rd shot had initial nausea, then 10 hrs after shot, felt weak, dizzy, achy, couldn't walk; had possible seizure, eyes rolled up, body tremor, T100.3. Seen in ER.
Severe vertigo or dizziness and nausea that lasted around 4 hours. After the 1st two hours, I took a couple of aspirins which had me sweating initially and seemed to help a little. I was finally able to leave work around 10 am, at which time I went to bed for several hours. When I got up, the severeness was gone but mildly lingering. As of today, there is a small hint of dizziness in the background, but I feel much better.
Patient presented to pharmacy on Friday 10/26/2018 with right arm swollen, and red. Felt warm to the touch. We checked the VAR and the right arm was the arm the PNEUMOVAX was given in. The left arm he received FLUZONE and there was no swelling redness etc, normal appearance. We recommended over the counter antihistamines and contacting his PCP, patient asked if he could try putting ice on it. Patient returned to pharmacy and said his doctor's office told him to come back to the pharmacy and check with them on Monday. Patient stated he would head home and if he got worse call emergency. We advised the patient to visit urgent care as soon as he left he pharmacy to be evaluated by a physician.
Rebound Covid 1 week after completing antiviral; Rebound Covid 1 week after completing antiviral; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Jul2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 50 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: SYNTHYROID; T3. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Rebound Covid 1 week after completing antiviral". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: unknown results, notes: indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: other medication in 2 weeks product: Synthyroid and T3. other medication in 2 weeks brand; Compounded  drugs. Adverse event - Rebound Covid 1 week after completing antiviral.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
A report received from a parent of a consumer on 11/12/2002, concerning a 9 year old vaccinee who experienced insomnia within days of receiving Fluvirin on 11/01/2002. The vaccinee experienced insomnia within days of receiving Fluvirin. the vaccinee experienced difficulty in falling asleep on 3 different occasions (dates unknown). Nothing had changed in the vaccinee's daily routine or medications. At the time of reporting, the vaccinee had not yet recovered.
pt brought to hospital ED after a fall at home; son reports generalized weakness and increased falling over last week; found to have a positive COVID test; COVID PNA; given dexamethasone; developed fever and worsening respiratory failure; O2 supplement; transitioned to comfort care and pt expired in the hospital
This patient had Pneumovax administered on 01/22/01, at approximately 1:30 PM. A few hours later the patient noticed discomfort (achy) in the left arm, became "feverish", felt "achy". She called the MD after contacting the health dept and complained of rapid heart beat, light headedness, mild sternal chest pain, slight sob. She was admitted to the hospital on 01/23/01. The patient was placed on Ancef foe cellulitis of the left upper arm and aqua-K pad. The patient's sickness dramatically improved and the patient was discharged on 01/26/01.
A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching and unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching on an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a 44 year old female vaccinee developed redness and swelling at the injection site, which was also itchy after receiving Fluvirin on 10/14/03. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of April 2004. No follow up pending. All information received.
Cough and eye redness (may have begun before vaccine dose). BP 138/93 (pulse 74), 98% O2 sat.
This spontaneous report as received from a 63 years old female patient of unknown age. The patient was vaccinated with ZOSTAVAX (lot# was unknown) during the second week of June, 12. No concomitant medications were reported. On unknown date two to three weeks after vaccination in 2012 the patient experienced zoster on her thoracic/back area. The patient was seen by the physician. Antivirals was given for the treatment. The outcome of zoster on her thoracic/back area was unknown. The relatedness for zoster on her thoracic/back area was unknown for ZOSTAVAX. Additional information has been requested.
Significant shoulder pain in vaccinated arm that impacted movement, worst at night. Started day after immunization given and lasted 8 days.
The evening of the vaccine I got a rash on my trunk and a ulcer on my tongue. The ulcer was toward the back of my tongue.  I felt drunk. The rash was on my trunk near where my bra is. It was a strawberry rash and I took some Benadryl it lasted three days. A few days later I started to get leg cramps like my legs were tired. On the right leg it went up into my thigh and my hip. It was cramping sensation that was constant and lasted for a week. It helped if I put my feet up it improved. Overall the leg cramps lasted for two weeks. I am recovered right now and the symptoms have not returned.
Pt refused to wait 15 mins. after vaccination as he had flu vaccine before. While walking out of store he fell backward and hit his head near store entrance. His head was bleeding but was aware of situation. Store manager called 911 and paramedics took him to hospital.
Runny nose, sensation of throat closing up, difficulty swallowing.  I could continue breathing nasally and could also drink water.  Event cleared up around 6:00 PM the same day (date of vaccination).
The patient received her first Covid injection on 1/ 7.  The next day she noticed palpitations and dizziness.  She states she had elevated heart rates at times up to 130.  The symptoms have come and gone since the vaccine was administered.  She has also been treated for an ongoing dental infection.
Vaccination site swelling; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.  No Medical History information was reported.  In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus). At the time of the report, VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE PRURITUS (Vaccination site pruritus) had not resolved.  No concomitant medication information was reported. No treatment medication information was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Fever 101.8 without antipyretics, 10/31/2009 10:15 PM fever of 102.8 without Tylenol/Advil.
Information has been received from a health professional concerning a female who on 30-MAY-2007 was vaccinated subcutaneously in the left quadrant, with varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced local reaction around the injection site. "Symptoms included a low grade fever, "large round circle" of swelling, redness and a little heat around the injection site." Subsequently, the patient recovered from local reaction around the
36 Hours following the vaccine shot, I noticed a number of dark spots under my arms and on my back. A trip to the Dermatologist on Monday 2/15/2021 determined that the vaccine had caused most if not all of the Seborrheic Keratoses (SK's) skin growths on my body to change color to a blue color. Four or the SK's were removed and sent to the lab for biopsy. The result came back as irritated SK's but no mention was made of the discoloration. After one week Friday (2/19), the blue color began to fade and by Sunday (2/20) the smaller of the SK's had returned to their original color while the larger still retain some of the blue color. During this time I felt fine.
c/o sharp pains lt deltoid area p/Td inject; that continues p/13 days from inject date; tx heat-ASA;
no adverse event; on 29JUN2019 a patient was administered MMRII that expired on 13JUN2018; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided.  On 29-JUN-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), 0.5 milliliter (lot # M029919, expiry date 13-JUN-2018; strength and route of administration were not reported) for prophylaxis. No additional adverse events were reported.
C/o pain in throat, just below adam's apple, shortly after receiving vaccines. Pain persisted with swallowing. Denied SOB, resp distress. Swelling of lips or tongue. No rash. Contacted primary provider-advised to proceed to ER if sx progressed. Follow up phone call on 2-11-15: patient went to ER. Was given a dose of steroid and discharged sx gradually resolved.
This is a spontaneous report as received from a Registered Nurse. The nurse reported that unspecified patients were vaccinated on unspecified dates with improperly stored doses of VARIVAX lot # L042267, expiration 27-OCT-2017; M-M-R II; lot number L026551, expiration 16-JUL-2017; and PROQUAD lot number L9465057 expiration 17-MAY-2017. No adverse effect reported. No further information received. Lot number L9465057 is an invalid lot number for PROQUAD. This is one of several reports from the same reporter. Additional information has been requested.